KRW 6250.0
(-2.5%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 25.37 Billion KRW | 16.77% |
2022 | 21.72 Billion KRW | 87.83% |
2021 | 11.56 Billion KRW | -33.25% |
2020 | 17.33 Billion KRW | 89.4% |
2019 | 9.15 Billion KRW | 6.69% |
2018 | 8.57 Billion KRW | 29.31% |
2017 | 6.63 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 29.12 Billion KRW | -8.73% |
2024 Q1 | 31.9 Billion KRW | 25.76% |
2023 Q3 | 31.06 Billion KRW | 7.01% |
2023 Q4 | 25.37 Billion KRW | -18.34% |
2023 FY | 25.37 Billion KRW | 16.77% |
2023 Q2 | 29.03 Billion KRW | -1.82% |
2023 Q1 | 29.57 Billion KRW | 36.11% |
2022 Q3 | 27.14 Billion KRW | 64.6% |
2022 Q4 | 21.72 Billion KRW | -19.95% |
2022 Q2 | 16.49 Billion KRW | -1.25% |
2022 Q1 | 16.7 Billion KRW | 44.36% |
2021 Q4 | 11.56 Billion KRW | -52.91% |
2021 Q3 | 24.56 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 15.04 Billion KRW | -68.604% |
InBody Co.,Ltd | 29.41 Billion KRW | 13.756% |
Curexo Inc. | 31.77 Billion KRW | 20.143% |
Seegene, Inc. | 137.63 Billion KRW | 81.566% |
i-SENS, Inc. | 83.54 Billion KRW | 69.63% |
Gencurix Inc. | 581.02 Million KRW | -4266.694% |
Sugentech Inc. | 7.01 Billion KRW | -261.436% |
L&C Bio Co., Ltd | 46.28 Billion KRW | 45.188% |